| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO &President | Director | EVP And CMO
2 companies
Kewalramani Reshma is a Director at DNA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $59.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sale+OE | 2,074 | $239.44 | $496,599.51 | -1.4% | |
| Nov 25, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sale+OE | 4,692 | $219.37 | $1,029,284.04 | -26.4% | |
| Nov 15, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sell | 61 | $205.95 | $12,562.95 | -0.5% | |
| Nov 8, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sale+OE | 509 | $199.00 | $101,291.00 | -3.7% | |
| Oct 30, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sale+OE | 3,057 | $199.00 | $608,343.00 | -18.9% | |
| Oct 22, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sell | 638 | $189.00 | $120,582.00 | -4.6% | |
| May 15, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP And CMO | Sell | 241 | $165.41 | $39,863.81 | -1.7% |